Natural history of estrogen receptor-negative, progesterone receptor-positive breast cancer

International Journal of Biological Markers

Volumn 17, Issue 3, 2002, Pages 196-200

  Nikolic Vukosavljevic, Dragica ^a   Kanjer, K ^a   Neskovic Konstantinovic, Z ^a   Vukotic, D ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

Biological aggressiveness; Breast carcinoma; Steroid hormone receptor phenotypes

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

ADULT; AGED; ARTICLE; ASSAY; AXILLARY LYMPH NODE; BIOCHEMISTRY; BREAST CANCER; BREAST CARCINOMA; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PATIENT MONITORING; PHENOTYPE; STATISTICAL SIGNIFICANCE;

EID: 0036662549     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460080201700309     Document Type: Article

References (23)

1. Thorpe SM. Estrogen and progesterone receptor determination in breast cancer. Technology, biology and clinical significance. Acta Oncol 1988; 27: 1-19.
2. Muldoon TG. Regulation of steroid hormone receptor activity. Endocrine Rev 1980; 1: 339-64.
3. Horowitz KB, McGuire WL, Pearson OH, Segaloff A. Predicting response of endocrine therapy in human breast cancer. A hypothesis. Science 1975; 189: 726-7.
4. Keshgegian AA, Cnaan A. Estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Poor clinical outcome. Arch Pathol Lab Med 1996; 120: 970-3.
5. American Joint Committee on Cancer. Manual for staging of cancer, 3rd ed. Philadelphia: JB Lippincott, 1987.
6. Scarff RF, Torloni H. Histologic typing of breast tumors: International histological classification of tumors II. Geneva: World Health Organization 1968; 19.
7. Bloom HJG, Richardson WW. Histological grading in breast cancer. Br J Cancer 1957; 11: 359-77.
8. EORTC Breast Cancer Cooperative Group. Revision of the standards for the assessment of receptors in human breast cancer. Eur J Cancer 1980; 16: 1513-5.
9. Nikolic-Vukosavljevic D, Brankovic-Magic M, Polic D, Vlajic M, Vuletic L, Spuzic I. Estrogen dependence of primary breast cancer - correlation with histologic type and grade. Neoplasma 1992; 39: 299-304.
10. Nikolic-Vukosavljevic D, Brankovic-Magic M, Polic D, Jankociv R. Standardization of steroid hormone receptor assay. Yugoslav Med Biochem 1998; 17: 391-4.
11. Romain S, Laine Bidron C, Martin PM, Magdelénat H. Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group. Eur J Cancer 1995; 31A: 411-7.
12. Fisher B, Redmond C, Fisher ER, Caplan R. Relative worth of estrogen and progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node-negative breast cancer patients: Findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol 1988; 7: 1076-87.
13. Mathiesen O, Bonderup X, Carl J, Panduro J, Pedersen KO. The prognostic value of estrogen and progesterone receptors in female breast cancer. A single center study. Acta Oncol 1991; 30: 691-5.
14. Chevallier B, Mosseri V, Dauce JP, Bastit P, Julien JP, Asselain B. A prognostic score in histological node negative breast cancer. Br J Cancer 1990; 61: 436-40.
15. Wittliff JL. Steroid-hormone receptors in breast cancer. Cancer 1984; 53: 630-43.
16. Mirecki DM, Jordan VC. Steroid hormone receptors and human breast cancer. Lab Med 1985; 16: 287-94.
17. Muresan Z, Dutu R, Voiculetz N. Relationships of steroid hormone receptors, age, and histological characteristics in human breast cancer. Neoplasma 1986; 33: 371-7.
18. Wilking N, Rutquist LE, Nordenskjold B, Skoog L. Steroid receptor levels in breast cancer. Relationships with age and menopausal status. Acta Oncol 1989; 28: 807-10.
19. Anonymous. Breast cancer estrogen and progesterone receptors: Associations with patients' clinical and epidemiologic characteristics. GIVIO (Interdisciplinary Group for Cancer Care Evaluation), Italy. Tumori 1991; 77: 472-8.
20. Nikolic-Vukosavljevic D, Vasiljevic N, Brankovic-Magic M, Polic DJ. Variations in steroid hormone receptor content throughout age and menopausal periods, and menstrual cycle in breast cancer patients. Neoplasma 1996; 43: 163-9.
21. Clarke R, Lippman ME. Antiestrogen resistance: mechanisms and reversal. In: Teicher BA, ed. Drug resistance in oncology. New York: Marcel Dekker Inc., 1992; 501-36.
22. McGuire WL, Osborne CK, Clark GM, Knight WA. Steroid hormone receptors and carcinoma of the breast. Am J Physiol 1982; 243: 99-102.
23. Stewart HJ, Prescott R. Adjuvant tamoxifen therapy of dependence of receptor level (letter). Lancet 1985; 1: 573.